loadpatents
Patent applications and USPTO patent grants for Dhal; Pradeep.The latest application filed is for "site-specific antibody-drug conjugation through glycoengineering".
Patent | Date |
---|---|
Site-specific Antibody-drug Conjugation Through Glycoengineering App 20220089763 - Pan; Clark ;   et al. | 2022-03-24 |
Site-specific antibody-drug conjugation through glycoengineering Grant 11,130,816 - Pan , et al. September 28, 2 | 2021-09-28 |
Antigenic Respiratory Syncytial Virus Polypeptides App 20210017237 - Nabel; Gary J. ;   et al. | 2021-01-21 |
Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugate Grant 10,806,797 - Kadereit , et al. October 20, 2 | 2020-10-20 |
Hyperglycosylated Binding Polypeptides App 20200140564 - PAN; Clark ;   et al. | 2020-05-07 |
Conjugates Comprising An Glp-1/glucagon/gip Triple Receptor Agonist, A Linker And Hyaluronic Acid App 20200023070 - Kadereit; Dieter ;   et al. | 2020-01-23 |
Hyperglycosylated binding polypeptides Grant 10,494,439 - Pan , et al. De | 2019-12-03 |
Site-specific Antibody-drug Conjugation Through Glycoengineering App 20190233531 - Pan; Clark ;   et al. | 2019-08-01 |
Site-specific antibody-drug conjugation through glycoengineering Grant 10,214,589 - Pan , et al. Feb | 2019-02-26 |
Amine functional polyamides Grant 10,113,032 - Dhal , et al. October 30, 2 | 2018-10-30 |
Prodrugs Comprising An Glp-1/glucagon Dual Agonist Linker Hyaluronic Acid Conjugate App 20180289822 - KADEREIT; Dieter ;   et al. | 2018-10-11 |
Hyperglycosylated Binding Polypeptides App 20170369584 - PAN; Clark ;   et al. | 2017-12-28 |
Site-specific Antibody-drug Conjugation Through Glycoengineering App 20170267774 - Pan; Clark ;   et al. | 2017-09-21 |
Hyperglycosylated binding polypeptides Grant 9,701,753 - Pan , et al. July 11, 2 | 2017-07-11 |
Site-specific antibody-drug conjugation through glycoengineering Grant 9,580,511 - Pan , et al. February 28, 2 | 2017-02-28 |
Amine Functional Polyamides App 20160208046 - DHAL; Pradeep ;   et al. | 2016-07-21 |
Amine functional polyamides Grant 9,326,994 - Dhal , et al. May 3, 2 | 2016-05-03 |
Hyperglycosylated Binding Polypeptides App 20150079070 - PAN; Clark ;   et al. | 2015-03-19 |
Site-specific Antibody-drug Conjugation Through Glycoengineering App 20140294867 - PAN; Clark ;   et al. | 2014-10-02 |
Amine Functional Polyamides App 20140275469 - DHAL; Pradeep ;   et al. | 2014-09-18 |
Amido-amine Dendrimer Compositions App 20140219951 - DHAL; PRADEEP ;   et al. | 2014-08-07 |
Amine Condensation Polymers As Phosphate Sequestrants App 20140044671 - Huval; Chad C. ;   et al. | 2014-02-13 |
Sulfone Polymer Compositions App 20130266533 - DHAL; Pradeep ;   et al. | 2013-10-10 |
Iron(II)-Containing A Treatments for Hyperphosphatemia App 20130243720 - Huval; Chad ;   et al. | 2013-09-19 |
Iron(II)-Containing Treatments for Hyperphosphatemia App 20100135950 - Huval; Chad ;   et al. | 2010-06-03 |
Composition of matter comprising an imprinted matrix exhibiting selective binding interactions through chelated metals Grant 5,310,648 - Arnold , et al. May 10, 1 | 1994-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.